Molecular markers and clinical studies

Basic and clinical research is progressing at a rapid pace in all areas of medicine, offering patients and treating physicians an increasing wealth of new and improved therapeutic options.

In the field of bladder cancer, too, there are now a number of approaches that take into account the individual clinical parameters of the patient and molecular changes in the tumor tissue. In our Clinical Department, we offer the latest standards in the field of molecular diagnostics of tumor tissue. Following on from this, we discuss optimized treatment concepts tailored to the patient or the possibility of inclusion in a clinical trial.

Immunotherapy, which is now being used more and more frequently in many areas of tumor treatment, can in most cases only be carried out after certain specific tests have been performed.

We will be happy to answer your questions about these new possibilities in our urological oncology consultation hours.